- Disease-modifying
antirheumatic drugs (
DMARDs)
comprise a
category of
otherwise unrelated disease-modifying
drugs defined by
their use in
rheumatoid arthritis...
- one
might argue that the
class of disease-modifying anti-rheumatic
drugs (
DMARD) is
composed by one
element ("disease-modifying") that
albeit vaguely designates...
-
among others, is an
immunosuppressive disease-modifying
antirheumatic drug (
DMARD), used in
active moderate-to-severe
rheumatoid arthritis and
psoriatic arthritis...
- inhibitor)
Probenecid (uricosuric)
Sulfasalazine (anti-inflammatory
agent and a
DMARD)
Sumatriptan (antimigraine triptan) Brayfield, A, ed. (2
February 2011)...
- (NSAIDs).
corticosteroid injections. Disease-modifying anti-rheumatic drug (
DMARD).
Anatomically close but
separate conditions are: Apophysitis, inflammation...
-
antirheumatic drugs (
DMARDs), such as
hydroxychloroquine and methotrexate, may be used to try to slow the
progression of disease.
Biological DMARDs may be used...
- a TNF inhibitor-type
biological disease-modifying anti-rheumatic drug (
DMARD). The goal of
treatment is to
achieve minimal disease activity or low disease...
-
arthritis is
DMARD monotherapy (Methotrexate preferred). In
moderate or
severe disease activity, it is
recommended to
combine conventional DMARDs, add a TNF-α...
- who are
intolerant to one or more disease-modifying
antirheumatic drugs (
DMARDs).
Upadacitinib may be used as
monotherapy or in
combination with methotrexate...
- used
medications include NSAIDs, TNF inhibitors, IL-17 antagonists, and
DMARDs.
Glucocorticoid injections are
often used for
acute and
localized flare-ups...
